Amyotrophic lateral sclerosis (ALS): Current and Emerging Treatment Landscape

More than 20 years after the first-drug was approved for the treatment of ALS, new and emerging therapies are changing the treatment landscape of ALS.

Bromberg MB. Amyotroph Lateral Scler. 2010;11:110-115. Fiorentino G et al. Degener Neurol Neuromuscul Dis. 2018;8:55-61. Edaravone (MCI-186) ALS 19 Study Group. Lancet Neurol. 2017;16:505-512. Cedarbaum JM et al. J Neurol Sci. 1999;169:13-21.

Dr. Raghav Govindarajan has a working relationship with the companies listed:
AbbVie Inc., Alexion Pharma, Mitsubishi Tanabe Pharma